StonvexLoading…
StonvexStonvexStonvexCore line items from RKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.94B | $6.70B | $4.00B | $2.40B |
Operating Income | $400.00M | $-214.00M | $-383.04M | $-198.84M |
Net Income | $297.00M | $-68.00M | $-136.02M | $-12.17M |
EPS (Diluted) | $0.10 | $-0.05 | $-0.17 | $-0.08 |
Total Assets | $59.44B | $60.69B | $33.58B | $30.36B |
Total Liabilities | $36.21B | $37.79B | $24.72B | $22.91B |
Cash & Equivalents | $2.69B | $2.70B | $5.84B | $5.09B |
Free Cash Flow OCF − CapEx | $1.81B | $-4.02B | $-2.75B | $-2.68B |
Shares Outstanding | 2.85B | 1.32B | 815.63M | 159.64M |